Skip to main content
Signal8

Terrillion Scott

SEC insider (Form 3/4/5 filer). CIK 0001706426. SEC'Y; CHIEF COMPLIANCE & G.C. at Cara Therapeutics, Inc. (CARA). 1 reported Form 4/5 transaction since Sep 2024; latest on Feb 28, 2025. Located in STAMFORD, CT.

Companies Terrillion Scott has filed insider reports for

  • Cara Therapeutics, Inc. (CARA): Officer, SEC'Y; CHIEF COMPLIANCE & G.C.
Terrillion Scott profile photo

Terrillion Scott

CIK: 0001706426

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cara Therapeutics, Inc. logo
CARA

Cara Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Cara Therapeutics, Inc. logo
    CARA

    Cara Therapeutics, Inc.

    Feb 28, 2025
    Sale
    Direct
    163 shares at avg. $4.76$775.88

1-1 of 1